Company
United StatesPublic company, NASDAQ: NVCRNovocure Inc. (NASDAQ: NVCR), Sparks, NV – FDA Inspections
Inspection records and compliance data for Novocure Inc. in Sparks, NV. 1 FDA inspection on record, last inspected November 16, 2023. Publicly traded as NASDAQ: NVCR.
Company Profile
This profile covers Novocure Inc. based in Sparks, NV, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected November 16, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 16, 2023 | Not classified | Medical Devices & Rad Health | 1225728 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novocure Inc.
Stock ticker
NVCR
Exchange
NASDAQ
Share price
$11.72
Market cap
$1.4B
Price as of
November 13, 2026
FEI Number
3027929472
Address
2555 Usa Pkwy Ste 104a, Sparks, NV 89437-5609, United States
Country
United States
ID: 656419b1-8442-48b8-95b7-b4dc88dffcc7